FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned is one of the latest updates being tracked by Novexa News from NPR News. The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
The story falls under the Technology desk and may matter to readers following public affairs, markets, technology, communities, policy decisions, or global developments connected to the subject. The available feed detail is limited, so this report stays close to confirmed information instead of adding unverified claims.
Novexa News will continue watching for official statements, clearer timelines, responses from affected parties, and independent confirmation from credible sources. Editorial review is recommended before heavy promotion if the story involves legal, political, health, crime, or conflict-sensitive details.
Source: NPR News via npr.org - https://www.npr.org/2026/08/01/nx-s1-5897441/fda-mrna-moderna-flu-vaccine
Image credit: Photo by panumas nikhomkhai on Pexels - https://www.pexels.com/photo/computer-server-in-data-center-room-17489156/
Comments
No approved comments yet.
